Pfizer 25 LLN Pill - tan round, 8mm
Generic Name: lorlatinib
Pill with imprint Pfizer 25 LLN is Tan, Round and has been identified as Lorbrena 25 mg. It is supplied by Pfizer Inc.
Lorbrena is used in the treatment of Non-Small Cell Lung Cancer and belongs to the drug class multikinase inhibitors. Lorbrena 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer 25 LLN
Lorbrena
- Generic Name
- lorlatinib
- Imprint
- Pfizer 25 LLN
- Strength
- 25 mg
- Color
- Tan
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0227
More about Lorbrena (lorlatinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
